2. Re-evaluation of the predictive value of anterior cruciate ligament and anti-β2GP 1 antibody for thrombosis in patients with systemic lupus erythematosus: Deng Xiaoling and Liu Xiaoyan (correspondent) from the perspective of the real world. International Rheumatology, 2012,32 (12): 3881-6.
3. RANKL down-regulates the expression of CXCR6 on the cell surface through JAK2/STAT3 signaling pathway during osteoclast formation. Li Chi, Zhao, Sun Li, Yao, Liu R, Huang Jiansheng, Liu Xiaoyan (author). Biochemistry and Biomedical Research Newsletter, 2012,429 (3-4):156-62.
4. Is it necessary to jointly detect anti-creatine protein antibodies in the diagnosis of rheumatoid arthritis? Zhao, Liu Xiaoyan (tied for the first author), Wang, Liu R and Li. Journal of Rheumatology, 20 10/0,37 (12): 2462-5.
5. Postmenopausal patients with systemic lupus erythematosus have mild illness and good prognosis. Deng Xiaoling and Liu Xiaoyan (correspondents). International Rheumatology, 2009 (5): 535-8.
6. Comparative study of circulating endothelial progenitor cells in patients with active systemic lupus erythematosus. Xiao Lideng, Li Xiaoxia, Liu Xiangyuan (correspondent), Sun Lin and Liu Rui. Rheumatology Immunology Department, 20 10/0,30 (11):1429-1436.
7. The significance of anti-CCP antibody in the diagnosis of rheumatoid arthritis by modifying the classification standard of 1987 ACR. Zhao, Liu Xiaoyan (tied 1 author), Wang, Li. Clinical rhein, 20 10/0,29 (1): 33-8.
8. Comparative study of low back pain diagnosed as spinal disease. Deng Xiaoling, Liu Xiaoyan (correspondent), Xu. Clinical Rheumatology, 2009,28 (8): 893-8.
9. Expression of murine sarcoma virus oncogenic homologous gene B 1 protein in synovial fluid of rheumatoid arthritis and its clinical significance. Zhao Jinxia, Sun Lin, Zhang Yingjian, Zhang Xia, Li Ru and Liu Xiangyuan (correspondents). Chinese Journal of Rheumatology, 20 13, 17 (7): 446-49.
10. Research progress on inflammatory mechanism of gout. Wu Dong, Zhao Jinxia, Sun Lin and Liu Xiangyuan (correspondents). Chinese Journal of Rheumatology, 20 14,18 (2):128-130.
1 1. Expression of galectin in umbilical cord mesenchymal stem cells. Sun Lin, Zhang Yingjian, Zhao Jinxia, Yao, Xu Ning, Rui Liu, (correspondent). Journal of Peking University (Medical Edition), 2013,45 (3): 452.
The role of 12.JAK2/STAT3 signaling pathway in the differentiation of RAW264.7 cells into osteoclasts induced by RANKL. Zhao Jinxia, Yao, Rui Liu, (correspondent). China Journal of Osteoporosis, 20 13, 19(5):
13. Detection and significance of anti-cyclic citrullinated peptide antibodies of IgG, IgA and IgM subtypes in early rheumatoid arthritis. Zhang Yingjian, Zhao Jinxia,,, Li Guiye, (correspondent), Li. Chinese Journal of Rheumatology, 20 13, 17 (65438).
14. Attention should be paid to the diagnosis and treatment of senile rheumatism. Zhao xiang yuan. Chinese Journal of Elderly Multiple Organ Diseases, 20 12,11(12): 881-884.
15. The key to the treatment of refractory gout is uric acid. , Zheng,. Journal of Peking University (Medical Edition), 2012,44 (2):168-170.
16. Detection of antibody against oncogenic homologue B/kloc-0 of murine sarcoma virus and its significance in the diagnosis of rheumatoid arthritis. , Zhao Jinxia,, Li Ru, (correspondent), Li. Journal of Peking University (Medical Edition), 2012,44 (2): 65438.
17. Hypouricemic treatment of gout can not be ignored (monograph). Liu Xiangyuan. Chinese Journal of Rheumatology, 20 10, 14 (6): 36 1-363.
18. Research progress on prognostic indicators of TNF-α antagonists in the treatment of rheumatoid arthritis. Zhao Jinxia and Liu Xiangyuan (correspondents). China Journal of Clinical Medicine, 20 10/0,4 (4): 447-449.
19. Progress in treatment of acute gout. Liu Xiangyuan, Li Shuqiang. China Journal of Clinical Medicine, 2009,3 (3): 71-73.
20. The choice of contraceptive methods for female patients with rheumatism. Liu Xiangyuan. Chinese Journal of Rheumatology, 2009,13 (1): 60-61.
2 1. Attention should be paid to the intensive treatment of rheumatoid arthritis (monograph). Liu Xiangyuan. Chinese Journal of Rheumatology, 2009,13 (11): 729-731.
22. Progress in the treatment of gout with hypouricemia. Liu Xiangyuan, Chinese Journal of Internal Medicine, 2008,47 (11): 959-960.
23. Treatment of refractory tophi gout. Liu Xiangyuan. China Journal of Clinical Medicine, 2008,2 (6): 619-622.
24. Prevention and treatment of adverse reactions of cyclophosphamide in the treatment of systemic lupus erythematosus. Liu Xiangyuan, Xu Ning, Li Shengguang. Chinese Journal of Rheumatology, 2008, 12(3): 207-209.
25. Differential diagnosis of chronic low back pain. Liu Xiangyuan, Li Shengguang. China Journal of General Medicine, May 2006 (10): 632-634.
26.B27-related anterior uveitis. Liu Xiangyuan, Xiao Yulan, Li Shengguang, Tang Lijun, Zhang Liyun. Chinese Journal of Rheumatology, 2006, 10 (4): 244-247.
27. Biological agents for the treatment of systemic lupus erythematosus. Liu Xiangyuan, Li Shengguang, Huang Feng. China Journal of General Medicine, May 2006 (1): 32-34.
28. Investigation of hyperuricemia in the elderly and analysis of its influencing factors. Liu Xiangyuan, Xiao Yulan, Ren Suqin, Tang Lijun, Zhang Liyun. Chinese Journal of Rheumatology, 2005,9 (5): 280-283.
29. Clinical analysis of 24 cases of low back pain misdiagnosed as spondyloarthropathy. Liu Xiangyuan, Huang Feng. Chinese Journal of Rheumatology, September 2005 (10): 610-614.
30. Progress in the treatment of fibromyalgia syndrome. Liu Xiangyuan, Huang Feng, Journal of Clinical Drugs, 2005,3 (1): 33-37.
3 1. Anti-B cell therapy for rheumatoid arthritis. Liu Xiangyuan, Huang Feng. Chinese Journal of Rheumatology, September 2005 (11): 696-697.
32. Treatment status of Wegener's granuloma. Liu Xiangyuan, Huang Feng. Chinese journal of drug application and monitoring Magazine, 2005,2 (3): 30-33.
33. Expression of HLA-DM and -DR genes in patients with rheumatoid arthritis in Han nationality. Liu Xiangyuan, Zhu Jiping, Min Weiqi, Huang Jiansheng. China medicine and clinic. 2003,3( 1): 18-20.
34. Analysis of HLA-DM gene polymorphism in patients with rheumatoid arthritis. Liu Xiangyuan, Min Weiqi, Huang Feng, Li Shengguang. Journal of College of Military Medical Continuing Education, 2002,23 (1): 8-10.
35. Clinical application of antimalarial drugs in systemic lupus erythematosus. Liu Xiangyuan, Huang Feng. China Journal of New Drugs, 2002, 1 1(4):274-277.
36. 86 cases of systemic sclerosis were treated with calcium sodium edetate. Liu Xiangyuan, Huang Zibo, Huang Feng. China Journal of New Drugs, 200 1, 10(8):530-322.
37. Systemic lupus erythematosus complicated with acute gangrene. , Shang, Huang Cibo, Chinese Journal of Internal Medicine, 2000,39 (9): 615-616.
38. A comparative study of Behcet's disease between men and women. Liu Xiangyuan, Li Shengguang, Shi Guiying, et al. Chinese Journal of Rheumatology, 2000,4 (2): 82-84.
39. Clinical significance of Raynaud's phenomenon in systemic lupus erythematosus. Liu Xiangyuan, Lin Jun, Huang Feng and Huang Zibo. Chinese Journal of Rheumatology, 2000,4 (3):175-177.
40. The expression of interleukin -6 and its receptor in peripheral blood of patients with systemic lupus erythematosus. Liu Xiangyuan, Lin Hong, Yuan Guohua, Huang Feng. Chinese Journal of Internal Medicine.1999,38 (7): 448-50.
4 1. Sjogren's syndrome complicated with complete renal tubular acidosis. Liu Xiangyuan, Du Zhuanmin, Yuan Guohua and Huang Cibo. Journal of Military Medical College,1999,20 (4): 254-255.
42. Correlation between gastrointestinal injury and Helicobacter pylori infection in patients with rheumatoid arthritis. Liu Xiangyuan, Shi Guiying. Chinese Journal of Rheumatology,1999,3 (2):106-10.
43. Comparative analysis of negative and positive ankylosing spondylitis of HLA-B27. Liu Xiangyuan, Wang Kuanting, Zhao Wei, Huang Feng. Chinese Journal of Rheumatology,1998,3:143-146.
44. Sjogren syndrome and renal tubular acidosis. Liu Xiangyuan, Li Chunxian and Huang Cibo. Chinese journal of practical internal medicine, 1998, 18 (12): 753-754.